Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Accounts Payables (2016 - 2020)

Historic Accounts Payables for Forte Biosciences (FBRX) over the last 5 years, with Q3 2020 value amounting to $1.5 million.

  • Forte Biosciences' Accounts Payables fell 3401.66% to $1.5 million in Q3 2020 from the same period last year, while for Sep 2020 it was $1.5 million, marking a year-over-year decrease of 3401.66%. This contributed to the annual value of $1.6 million for FY2019, which is 5390.72% down from last year.
  • Latest data reveals that Forte Biosciences reported Accounts Payables of $1.5 million as of Q3 2020, which was down 3401.66% from $2.6 million recorded in Q2 2020.
  • In the past 5 years, Forte Biosciences' Accounts Payables ranged from a high of $4.6 million in Q3 2018 and a low of $947000.0 during Q1 2017
  • Over the past 5 years, Forte Biosciences' median Accounts Payables value was $1.7 million (recorded in 2016), while the average stood at $2.1 million.
  • In the last 5 years, Forte Biosciences' Accounts Payables skyrocketed by 29471.4% in 2018 and then crashed by 5390.72% in 2019.
  • Over the past 5 years, Forte Biosciences' Accounts Payables (Quarter) stood at $1.7 million in 2016, then rose by 17.11% to $2.0 million in 2017, then surged by 74.47% to $3.4 million in 2018, then plummeted by 53.91% to $1.6 million in 2019, then dropped by 3.57% to $1.5 million in 2020.
  • Its Accounts Payables stands at $1.5 million for Q3 2020, versus $2.6 million for Q2 2020 and $1.6 million for Q1 2020.